Rat mammary cancer inhibition by a prolactin suppressor, 2-bromo-α-ergokryptine (CB 154)
- 1 August 1971
- journal article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 27 (8), 915-916
- https://doi.org/10.1007/bf02135741
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Evidence for a luteolytic function of prolactin in the intact cyclic rat using 2-Br-α-ergokryptine (CB 154)Cellular and Molecular Life Sciences, 1971
- Effects of prolactin or growth hormone on growth of carcinogen‐induced mammary tumors of adreno‐ovariectomized ratsInternational Journal of Cancer, 1970
- Suppression by Ergocornine and Iproniazid of Carcinogen-Induced Mammary Tumors in Rats; Effects on Serum and Pituitary Prolactin LevelsExperimental Biology and Medicine, 1970
- Growth inhibition of rat mammary carcinoma and endocrine changes produced by 2-Br-α-ergocryptine, a suppressor of lactation and nidationEuropean Journal of Cancer (1965), 1970
- Effects of ergocornine and 2-Br-α-ergokryptin (CB-154) on the formation of mammary hyperplastic alveolar nodules and the pituitary prolactin levels in miceCellular and Molecular Life Sciences, 1970
- Prolactin and mammary gland carcinogenesis. The problem of human prolactinInternational Journal of Cancer, 1970
- 2-Br-α-Ergokryptin: Beeinflussung von Fertilität und Laktation bei der RatteCellular and Molecular Life Sciences, 1968
- EXPERIMENTAL STUDIES ON THE EFFECT OF ERGOCORNINE METHANESULPHONATE ON THE LUTEOTROPHIC FUNCTION OF THE RAT PITUITARY GLANDActa Endocrinologica, 1962
- Recent Studies of the Hormonal Influence in Mouse Mammary TumorigenesisPublished by S. Karger AG ,1960